LAI Goldman Myla
SEC-identified person · CIK 1168581 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| West Pharmaceutical Services INC wst | Director | filed 2014 - 2026 |
| Quanterix Corp QTRX | Director | filed 2025 - 2026 |
| Akoya Biosciences, Inc. AKYA | Director | filed 2021 - 2025 |
| Sequenom INC SQNMD | Director | filed 2012 - 2016 |
| Laboratory Corp of America Holdings LH | EVP & Chief Medical Officer | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.